evidence vs. DILG Secretary Puno who will reportedly run for Philippine president.
There is evidence that the DILG office received, on 7/15/08 my registered letter, designated as letter No.0622, which contained a complaint against Manila Mayor Lim. Despite the fact that said Puno is supposed to obey R.A. 6713, up to July 27, 2009, he has not informed me what happened to said complaint.
Monday, July 27, 2009
Friday, July 24, 2009
International advisory vs. Manila: Mayor Lim, Vice Mayor Moreno; Secretary Puno of the Philippine Department of Interior and Local Government.
There is evidence that my letters addressed, to said officials, reached their offices. However, despite R.A. 6713 which said persons are supposed to obey,
they did not provide me with prompt, courteous, satisfactory, service.
The following statement is attributed to said Lim: "The law applies to all, otherwise, none at all.
My letters to said Puno contained complaints vs. said Lim.
I received a letter from a source identified as the Chief of Staff of said Lim: "Security lapses at shopping malls are not the concern of the City government, being
private entities." Does said statement mean that if persons are injured or killed due to security lapses in private entities their injuries or deaths are also not the concern of the City government of Manila?
Facts and Myths about Generic Drugs
http://www.fda.gov
Today, 7 in 10 prescriptions filled in the United States are for generic drugs. This fact sheet explains how generic drugs are made and approved and debunks some common myths about these products.
FACT: FDA requires generic drugs to have the same quality and performance as the brand name drugs.
* When a generic drug product is approved, it has met rigorous standards established by the FDA with respect to identity, strength, quality, purity and potency. Some variability can and does occur during manufacturing, for both brand name and generic drugs. When a drug, generic or brand name, is mass produced, very small variations in purity, size, strength and other parameters are permitted. FDA puts limits on how much variability in composition or performance of a drug is acceptable.
* Generic drugs are required to have the same active ingredient, strength, dosage form, and route of administration as the brand name (or reference) product. Generic drugs do not need to contain the same inactive ingredients as the brand product.
* Through review of bioequivalence data, FDA assures that the generic product will perform the same as its respective brand name (or reference) product. This standard applies to all generic drugs, whether immediate or controlled release.
* A generic drug must be shown to be bioequivalent to the reference drug; that is, it must be shown to give blood levels that are very similar to those of the reference product. If blood levels are the same, the therapeutic effect will be the same. In that case, there is no need to carry out a clinical effectiveness study and they are not required.
* All generic manufacturing, packaging and testing sites must pass the same quality standards as those of brand name drugs and the generic products must meet the same exacting specifications as any innovator brand name product. In fact, many generic drugs are made in the same plants as innovator brand name drug products.
* If an innovator of a brand name drug switches drug production to an alternative manufacturing site, or they change formulation of their brand name drug, these companies are held to the same rigorous manufacturing requirements as those that apply to generic drug companies.
FACT: Research shows that generics work just as well as brand name drugs.
* A recent study evaluated the results of 38 published clinical trials that compared cardiovascular generic drugs to their brand-name counterparts. There was no evidence that brand-name heart drugs worked any better than generic heart drugs. [Kesselheim et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21)2514-2526].
FACT: When it comes to price, there is a big difference between generic and brand name drugs. On average, the cost of a generic drug is 80 to 85% lower than the brand name product.
* An IMS National Prescription Audit shows that a typical formulary now charges $6 for generic medications, $29 for preferred branded drugs, and $40 or more for non-preferred branded drugs. [Aitken et al. Prescription drug spending trends in the United States: looking beyond the turning point. Health Aff (Millwood). 2009;28(1):w151-60].
* Independent research has shown that total prescription drug expenditures in the United States only increased by 4.0% from 2006 to 2007, with total spending rising from $276 billion to $287 billion. This is a sharp decrease from the 8.9% growth rate observed in prescription drug expenditures in 2006. One factor cited as a reason for the slowdown is an increase in availability and use of generic drugs [Hoffman et al. Projecting future drug expenditures--2009. Am J Health Syst Pharm. 2009;66(3):237-57].
Recently, misinformation in the media has raised concerns over generic drugs. Below are some common myths in circulation.
MYTH: People who are switched to a generic drug are risking treatment failure.
FACT: There is no evidence for this claim. Treatment failures can and do occur when taking generic or brand name drugs. If someone is switched to a generic drug around the time they are relapsing, they may attribute the problem to the switch.
* Many people who have recovered from major depression have a relapse despite continued treatment. These relapses have been shown in trials of long-term therapy. [Byrne and Rothschild. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry. 1998;59(6):279-88].
* Many people who are on a seizure medications will re-experience a seizure despite continued treatment on a single drug. The likelihood of re-experiencing a seizure, despite staying with the same drug product, goes up with time. [Brodie et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology. 2007;68(6):402-8].
* A percentage of people will re-experience gastric ulcers, despite an initial, positive response to and continued treatment with prescription strength antacids (cimetidine tablets; http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8131#nlm34067-9).
MYTH: Generic drugs cost less because they are inferior to brand name drugs.
FACT: Generic manufacturers are able to sell their products for lower prices, not because the products are of lesser quality, but because generic manufacturers generally do not engage in costly advertising, marketing and promotion, or significant research and development.
* When a brand name drug comes off patent and generic drugs are permitted to compete with the brand name drug, the generic products compete by offering lower prices. Unlike the manufacturers of brand name drugs, generic drug companies do not have significant expenses to recoup for advertising, marketing and promotion, or research and development activities.
MYTH: There are quality problems with generic drug manufacturing. A recent recall of generic digoxin (called Digitek) shows that generic drugs put patients at risk.
MYTH: Brand name drugs are safer than generic drugs.
FACT: FDA receives very few reports of adverse events about specific generic drugs. Most reports of adverse events are related to side effects of the drug ingredient itself.
* The monitoring of postmarket adverse events for all drug products, including generic drugs, is one aspect of the overall FDA effort to evaluate the safety of drugs after approval. In most cases, reports of adverse events generally describe a known reaction to the active drug ingredient.
Page Last Updated: 07/10/2009
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
There is evidence that my letters addressed, to said officials, reached their offices. However, despite R.A. 6713 which said persons are supposed to obey,
they did not provide me with prompt, courteous, satisfactory, service.
The following statement is attributed to said Lim: "The law applies to all, otherwise, none at all.
My letters to said Puno contained complaints vs. said Lim.
I received a letter from a source identified as the Chief of Staff of said Lim: "Security lapses at shopping malls are not the concern of the City government, being
private entities." Does said statement mean that if persons are injured or killed due to security lapses in private entities their injuries or deaths are also not the concern of the City government of Manila?
Facts and Myths about Generic Drugs
http://www.fda.gov
Today, 7 in 10 prescriptions filled in the United States are for generic drugs. This fact sheet explains how generic drugs are made and approved and debunks some common myths about these products.
FACT: FDA requires generic drugs to have the same quality and performance as the brand name drugs.
* When a generic drug product is approved, it has met rigorous standards established by the FDA with respect to identity, strength, quality, purity and potency. Some variability can and does occur during manufacturing, for both brand name and generic drugs. When a drug, generic or brand name, is mass produced, very small variations in purity, size, strength and other parameters are permitted. FDA puts limits on how much variability in composition or performance of a drug is acceptable.
* Generic drugs are required to have the same active ingredient, strength, dosage form, and route of administration as the brand name (or reference) product. Generic drugs do not need to contain the same inactive ingredients as the brand product.
* Through review of bioequivalence data, FDA assures that the generic product will perform the same as its respective brand name (or reference) product. This standard applies to all generic drugs, whether immediate or controlled release.
* A generic drug must be shown to be bioequivalent to the reference drug; that is, it must be shown to give blood levels that are very similar to those of the reference product. If blood levels are the same, the therapeutic effect will be the same. In that case, there is no need to carry out a clinical effectiveness study and they are not required.
* All generic manufacturing, packaging and testing sites must pass the same quality standards as those of brand name drugs and the generic products must meet the same exacting specifications as any innovator brand name product. In fact, many generic drugs are made in the same plants as innovator brand name drug products.
* If an innovator of a brand name drug switches drug production to an alternative manufacturing site, or they change formulation of their brand name drug, these companies are held to the same rigorous manufacturing requirements as those that apply to generic drug companies.
FACT: Research shows that generics work just as well as brand name drugs.
* A recent study evaluated the results of 38 published clinical trials that compared cardiovascular generic drugs to their brand-name counterparts. There was no evidence that brand-name heart drugs worked any better than generic heart drugs. [Kesselheim et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21)2514-2526].
FACT: When it comes to price, there is a big difference between generic and brand name drugs. On average, the cost of a generic drug is 80 to 85% lower than the brand name product.
* An IMS National Prescription Audit shows that a typical formulary now charges $6 for generic medications, $29 for preferred branded drugs, and $40 or more for non-preferred branded drugs. [Aitken et al. Prescription drug spending trends in the United States: looking beyond the turning point. Health Aff (Millwood). 2009;28(1):w151-60].
* Independent research has shown that total prescription drug expenditures in the United States only increased by 4.0% from 2006 to 2007, with total spending rising from $276 billion to $287 billion. This is a sharp decrease from the 8.9% growth rate observed in prescription drug expenditures in 2006. One factor cited as a reason for the slowdown is an increase in availability and use of generic drugs [Hoffman et al. Projecting future drug expenditures--2009. Am J Health Syst Pharm. 2009;66(3):237-57].
Recently, misinformation in the media has raised concerns over generic drugs. Below are some common myths in circulation.
MYTH: People who are switched to a generic drug are risking treatment failure.
FACT: There is no evidence for this claim. Treatment failures can and do occur when taking generic or brand name drugs. If someone is switched to a generic drug around the time they are relapsing, they may attribute the problem to the switch.
* Many people who have recovered from major depression have a relapse despite continued treatment. These relapses have been shown in trials of long-term therapy. [Byrne and Rothschild. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry. 1998;59(6):279-88].
* Many people who are on a seizure medications will re-experience a seizure despite continued treatment on a single drug. The likelihood of re-experiencing a seizure, despite staying with the same drug product, goes up with time. [Brodie et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology. 2007;68(6):402-8].
* A percentage of people will re-experience gastric ulcers, despite an initial, positive response to and continued treatment with prescription strength antacids (cimetidine tablets; http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8131#nlm34067-9).
MYTH: Generic drugs cost less because they are inferior to brand name drugs.
FACT: Generic manufacturers are able to sell their products for lower prices, not because the products are of lesser quality, but because generic manufacturers generally do not engage in costly advertising, marketing and promotion, or significant research and development.
* When a brand name drug comes off patent and generic drugs are permitted to compete with the brand name drug, the generic products compete by offering lower prices. Unlike the manufacturers of brand name drugs, generic drug companies do not have significant expenses to recoup for advertising, marketing and promotion, or research and development activities.
MYTH: There are quality problems with generic drug manufacturing. A recent recall of generic digoxin (called Digitek) shows that generic drugs put patients at risk.
MYTH: Brand name drugs are safer than generic drugs.
FACT: FDA receives very few reports of adverse events about specific generic drugs. Most reports of adverse events are related to side effects of the drug ingredient itself.
* The monitoring of postmarket adverse events for all drug products, including generic drugs, is one aspect of the overall FDA effort to evaluate the safety of drugs after approval. In most cases, reports of adverse events generally describe a known reaction to the active drug ingredient.
Page Last Updated: 07/10/2009
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Wednesday, July 22, 2009
Tuesday, July 21, 2009
International advisory vs. Bank of the Philippine Islands Midland branch. I have evidence against employees at said branch who were identified as: the Branch Business Manager, Ms. Delia L. Lao, Assistant Business Manager, Mr. Roberto Figuerroa Jr. and the Branch Service Associate Ms. Invy G. Conechado. Then, on July 21, 2009, an employee, identified as Assistant Business Manager attended first to a person who came after me.
Open letter to Councilman Jon Abalos
City Hall
Mandaluyong, Metro Manila
Are security lapses at private entities in Mandaluyong of no concern to you?
I witnessed security lapses at entrances to two private shopping areas in Mandaluyong. Because of said security lapses, I could have brought deadly weapons into said areas, endangering shoppers. I left written complaints at said areas regarding said security lapses. Months have passed by but authorities at said sites have not provided me with replies to said complaints.
For the benefit of customers, please, soonest, provide me with complete lists of products sold at Power Nut store in Mandaluyong; complete prices of said products; complete list of ingredients of said products. I have proof that Sen. Loren Legarda accepted my complaint vs. said store and that her representative referred said complaint to DTI Secretary Favilla. I have evidence vs. Mandaluyong Mayor and Mandaluyong Vice Mayor. I believe they violated R.A. 6713. Which government agency accepts complaints re violations of said law?
mis3624@yahoo.com
Advisory vs. Emerald Headway, Inc.
Based on evidence, said firm was the importer of PC Utilities magazine issue 115 which was sold to me by store identified as Power Books at Robinsons Place Manila. When I used the Norton Anti Virus program to scan the DVD contained in said magazine said program revealed unfavorable results regarding a program identified as Advanced URL Catalog. The image below is a copy of the results revealed by said Norton Anti Virus program. This is not the first time that said corporation imported said computer magazine with something wrong with the supplied DVD. Previously, I complained to the Department of Trade and Industry vs. said corporation.
open letter to Henry Sy/Tessie Sy-Coson SM
I have a complaint vs. SM Department store at SM City Manila. Please, soonest, provide me the complete address where the details of said complaint will be sure to reach you.
mis3624@yahoo.com
International advisory vs. DILG Secretary Puno who is allegedly a presidential aspirant.
I sent him a complaint vs. Manila Mayor Lim. Despite R.A. 6713, which he is required to obey, he did not provide me with prompt, courteous, and
satisfactory service regarding said complaint. Does he agree with the position of the Chief of Staff of the Office of the Mayor City of Manila that
security lapses at private entities are not the concern of the City government of Manila?
Open letter to Donny Tantoco ShopWise
I have a complaint vs. ShopWise store at Harrison Plaza, Manila. Please, soonest, provide me with the complete address where details of said complaint will be certain to reach you.
international advisory vs. Intercontinental Manila
which was a hotel and was located in Makati. For the benefit of customers, I sent a letter by registered mail to said hotel and I requested some information about said hotel. I have evidence that said letter was received by said hotel, but said hotel did not provide me with any reply until after I complained to the DTI BTRCP. Even after said Department of Trade and Industry Bureau of Trade Regulation and Consumer Protection endorsed my said letter to said hotel, said hotel, in a letter dated July 2, 2009, did not provide me with the proofs I requested. For example, my registered letter received by said hotel contained the following request: "If said hotel has a swimming pool, provide soonest to me, proofs, if any, that said pool is safe for swimming."
Said hotel did not provide me with any proofs that said swimming pool is safe for swimming by humans. The signature which appeared on said letter was
identified was being that of Charles Marshall General Manager.
International advisory vs. The Landmark food court manager. Said food court was at the Landmark building at Ayala Center Makat.
On April 20, 2009, said manager received, at the Landmark food court in the Landmark building at Ayala Center, Makati, my written complaint vs. personnel at the KFC fast food restaurant at said food court. Up to ______________, __, 20__, said manager has not informed what he did with said complaint. An image of said complaint is shown below.
Open letter to Councilman Jon Abalos
City Hall
Mandaluyong, Metro Manila
Are security lapses at private entities in Mandaluyong of no concern to you?
I witnessed security lapses at entrances to two private shopping areas in Mandaluyong. Because of said security lapses, I could have brought deadly weapons into said areas, endangering shoppers. I left written complaints at said areas regarding said security lapses. Months have passed by but authorities at said sites have not provided me with replies to said complaints.
For the benefit of customers, please, soonest, provide me with complete lists of products sold at Power Nut store in Mandaluyong; complete prices of said products; complete list of ingredients of said products. I have proof that Sen. Loren Legarda accepted my complaint vs. said store and that her representative referred said complaint to DTI Secretary Favilla. I have evidence vs. Mandaluyong Mayor and Mandaluyong Vice Mayor. I believe they violated R.A. 6713. Which government agency accepts complaints re violations of said law?
mis3624@yahoo.com
Advisory vs. Emerald Headway, Inc.
Based on evidence, said firm was the importer of PC Utilities magazine issue 115 which was sold to me by store identified as Power Books at Robinsons Place Manila. When I used the Norton Anti Virus program to scan the DVD contained in said magazine said program revealed unfavorable results regarding a program identified as Advanced URL Catalog. The image below is a copy of the results revealed by said Norton Anti Virus program. This is not the first time that said corporation imported said computer magazine with something wrong with the supplied DVD. Previously, I complained to the Department of Trade and Industry vs. said corporation.
open letter to Henry Sy/Tessie Sy-Coson SM
I have a complaint vs. SM Department store at SM City Manila. Please, soonest, provide me the complete address where the details of said complaint will be sure to reach you.
mis3624@yahoo.com
International advisory vs. DILG Secretary Puno who is allegedly a presidential aspirant.
I sent him a complaint vs. Manila Mayor Lim. Despite R.A. 6713, which he is required to obey, he did not provide me with prompt, courteous, and
satisfactory service regarding said complaint. Does he agree with the position of the Chief of Staff of the Office of the Mayor City of Manila that
security lapses at private entities are not the concern of the City government of Manila?
Open letter to Donny Tantoco ShopWise
I have a complaint vs. ShopWise store at Harrison Plaza, Manila. Please, soonest, provide me with the complete address where details of said complaint will be certain to reach you.
international advisory vs. Intercontinental Manila
which was a hotel and was located in Makati. For the benefit of customers, I sent a letter by registered mail to said hotel and I requested some information about said hotel. I have evidence that said letter was received by said hotel, but said hotel did not provide me with any reply until after I complained to the DTI BTRCP. Even after said Department of Trade and Industry Bureau of Trade Regulation and Consumer Protection endorsed my said letter to said hotel, said hotel, in a letter dated July 2, 2009, did not provide me with the proofs I requested. For example, my registered letter received by said hotel contained the following request: "If said hotel has a swimming pool, provide soonest to me, proofs, if any, that said pool is safe for swimming."
Said hotel did not provide me with any proofs that said swimming pool is safe for swimming by humans. The signature which appeared on said letter was
identified was being that of Charles Marshall General Manager.
International advisory vs. The Landmark food court manager. Said food court was at the Landmark building at Ayala Center Makat.
On April 20, 2009, said manager received, at the Landmark food court in the Landmark building at Ayala Center, Makati, my written complaint vs. personnel at the KFC fast food restaurant at said food court. Up to ______________, __, 20__, said manager has not informed what he did with said complaint. An image of said complaint is shown below.
Saturday, July 18, 2009
International open letter
to J.Binay - Mayor - City of Manila, Philippines and presidential aspirant
* I have evidence that my letters containing reports of security lapses at private
entities (malls. department stores, etc.) were received by your agent(s). Despite
R.A. 6713, neither you or your agent provided me with replies to said letters.
Because of said security lapses at said private entities, I could have brought
deadly weapons into said entities, endangering shoppers inside said entities.
* I was shortchanged of 100 pesos by an employee working inside SM Supermarket at
Ayala Center, Makati. I received a letter containing an apology for said short
changing. I forwarded said complaint to what was identified as the SM central
offices. Said letter was received but said offices did not provide
me with any information as to what was done with said complaint.
* Does the Makati government consider security lapses at private entities, in
Makati such as shopping centers, restaurants, etc.of no concern to the city
government?
International advisory vs Dong Puno - the director of the Philippine Department of Interior and Local Government and presidential aspirant. I have evidence that said department received my complaints vs. Alfredo S. Lim - Mayor of Manila, Philippines.
Despite R.A. 6713, which said department is required to obey, said
department did not provide me with prompt, courteous service regarding said complaints. I believe said Puno violated the said law. Based on reports,
said enforced the law against erring government persons. However, he did not
provide me with prompt, courteous and satisfactory service regarding my complaint
vs. said Lim.
to J.Binay - Mayor - City of Manila, Philippines and presidential aspirant
* I have evidence that my letters containing reports of security lapses at private
entities (malls. department stores, etc.) were received by your agent(s). Despite
R.A. 6713, neither you or your agent provided me with replies to said letters.
Because of said security lapses at said private entities, I could have brought
deadly weapons into said entities, endangering shoppers inside said entities.
* I was shortchanged of 100 pesos by an employee working inside SM Supermarket at
Ayala Center, Makati. I received a letter containing an apology for said short
changing. I forwarded said complaint to what was identified as the SM central
offices. Said letter was received but said offices did not provide
me with any information as to what was done with said complaint.
* Does the Makati government consider security lapses at private entities, in
Makati such as shopping centers, restaurants, etc.of no concern to the city
government?
International advisory vs Dong Puno - the director of the Philippine Department of Interior and Local Government and presidential aspirant. I have evidence that said department received my complaints vs. Alfredo S. Lim - Mayor of Manila, Philippines.
Despite R.A. 6713, which said department is required to obey, said
department did not provide me with prompt, courteous service regarding said complaints. I believe said Puno violated the said law. Based on reports,
said enforced the law against erring government persons. However, he did not
provide me with prompt, courteous and satisfactory service regarding my complaint
vs. said Lim.
Friday, July 17, 2009
public service advisory re all hospitals in the Philippines
It will benefit all prospective customers of all hospitals in the Philippines, including St. Luke's Medical Center, Makati Medical Center, Manila Doctors Hospitals, Medical Center Manila, etc. to obtain, in advance, full details and evidence regarding said hospitals' emergency rooms and the qualifications of the staff in said rooms as well as the other staff in said hospitals and the other equipment in said hospitals. I have evidence vs. St. Luke's Medical Center. Also,
based on information, the Bureau of Trade Relation and Consumer Protection endorsed to St. Luke's Medical Center my request for information about said hospital. I have not received any reply from said hospital. I have also had bad experience with Manila Doctors Hospital, Medical Center Manila, Philippine General Hospital. There were web sites on the Internet on how to choose an emergency room, how to choose a hospital.
open letter to people in Makati City, Metro Manila
Do you know what is the policy of the City Government of Makati regarding security lapses in private entities in Makati, such as shopping malls, restaurants, grocery stores? Does the Makati city government consider security lapses in restaurants, shopping malls, grocery stores, hotels as of no concern to it? If so,
it means that if you or a loved one are in a private entity in Makati and are injured or killed as the result of a security lapse in said entity, it will be of no concern to the city government in Makati.
warning vs. buying at SM department stores, SM supermarkets, SM HyperMart,etc. Based on the information on the registry return for my complaint letter, numbered 0650 and addressed to the SM corporate offices, said letter was received on April 14, 2009 by an agent of said offices. Up to July 17, 2009, no one from said offices has provided me with a reply to said letter.
Open letter to presidential aspirant Makati Mayor Binay
City Hall
Makati
Does the City government of Makati consider security lapses in private entities in
Makati as of no concern to said City government?
* I repeatedly experienced lax security at entrances to: Glorietta, Park Square 1,
SM Makati Power Plant, all in Makati. Because of said lax security, I repeatedly
could have brought dangerous weapons into said areas, to the detriment of shoppers
in said areas. I am willing to execute an affidavit regarding said lapses in said
areas.
* I was shortchanged of 100 Philippine pesos by an employee working at SM
Supermarket in SM Makati. I received a reply from said store admitting said
shortchanging. I sent a complaint regarding said shortchanging to what was
identified as the central offices of SM in Pasay City. There is proof that said
said letter was received by said offices. A reasonable amount of time has passed
but I have not received from said offices any reply to said letter. If you are
consumer oriented, please soonest help me obtain from either Henry Sy or Tessie
Sy Coson a reply to said complaint. Said reply must be accompanied by s sworn
affidavit that said reply is really their reply.
* I repeatedly sent letters addressed to you regarding security lapses at Ayala
Center Makati. Based on the evidence, said letters were received by your agent.
Over a year has passed since said some of the letters were received by your
agent. Provide soonest to me a a credible explanation why you did not provide me
with replies to said letter.
* Based on evidence, the Bureau of Trade Relation and Consumer Protection sent to
your office my complaint with evidence vs. the Makati Department of Health. What
is your decision regarding said complaint?.
* I have a complaint vs. The Landmark corporation and the KFC fastfood store at the
Landmark building. What, if any, are you going to do about it?
It will benefit all prospective customers of all hospitals in the Philippines, including St. Luke's Medical Center, Makati Medical Center, Manila Doctors Hospitals, Medical Center Manila, etc. to obtain, in advance, full details and evidence regarding said hospitals' emergency rooms and the qualifications of the staff in said rooms as well as the other staff in said hospitals and the other equipment in said hospitals. I have evidence vs. St. Luke's Medical Center. Also,
based on information, the Bureau of Trade Relation and Consumer Protection endorsed to St. Luke's Medical Center my request for information about said hospital. I have not received any reply from said hospital. I have also had bad experience with Manila Doctors Hospital, Medical Center Manila, Philippine General Hospital. There were web sites on the Internet on how to choose an emergency room, how to choose a hospital.
open letter to people in Makati City, Metro Manila
Do you know what is the policy of the City Government of Makati regarding security lapses in private entities in Makati, such as shopping malls, restaurants, grocery stores? Does the Makati city government consider security lapses in restaurants, shopping malls, grocery stores, hotels as of no concern to it? If so,
it means that if you or a loved one are in a private entity in Makati and are injured or killed as the result of a security lapse in said entity, it will be of no concern to the city government in Makati.
warning vs. buying at SM department stores, SM supermarkets, SM HyperMart,etc. Based on the information on the registry return for my complaint letter, numbered 0650 and addressed to the SM corporate offices, said letter was received on April 14, 2009 by an agent of said offices. Up to July 17, 2009, no one from said offices has provided me with a reply to said letter.
Open letter to presidential aspirant Makati Mayor Binay
City Hall
Makati
Does the City government of Makati consider security lapses in private entities in
Makati as of no concern to said City government?
* I repeatedly experienced lax security at entrances to: Glorietta, Park Square 1,
SM Makati Power Plant, all in Makati. Because of said lax security, I repeatedly
could have brought dangerous weapons into said areas, to the detriment of shoppers
in said areas. I am willing to execute an affidavit regarding said lapses in said
areas.
* I was shortchanged of 100 Philippine pesos by an employee working at SM
Supermarket in SM Makati. I received a reply from said store admitting said
shortchanging. I sent a complaint regarding said shortchanging to what was
identified as the central offices of SM in Pasay City. There is proof that said
said letter was received by said offices. A reasonable amount of time has passed
but I have not received from said offices any reply to said letter. If you are
consumer oriented, please soonest help me obtain from either Henry Sy or Tessie
Sy Coson a reply to said complaint. Said reply must be accompanied by s sworn
affidavit that said reply is really their reply.
* I repeatedly sent letters addressed to you regarding security lapses at Ayala
Center Makati. Based on the evidence, said letters were received by your agent.
Over a year has passed since said some of the letters were received by your
agent. Provide soonest to me a a credible explanation why you did not provide me
with replies to said letter.
* Based on evidence, the Bureau of Trade Relation and Consumer Protection sent to
your office my complaint with evidence vs. the Makati Department of Health. What
is your decision regarding said complaint?.
* I have a complaint vs. The Landmark corporation and the KFC fastfood store at the
Landmark building. What, if any, are you going to do about it?
Thursday, July 16, 2009
Worldwide advisory vs.:
Lim - Mayor of Manila, Philippines; Moreno - Vice Mayor of Manila, Philippines;
Binay - Mayor of Makati City, Philippines; Vice-Mayor of Makati, Philippines;
Benhur Abalos - Mayor of Mandaluyong City, Philippines; Vice-Mayor of Mandaluyong City Philippines;
Belmonte - Mayor of Quezon City, Philippines; Herbert Bautista - Vice Mayor of Quezon City,Philippines;
The Commissioner of the Civil Service Commssion - Philippines for not accepting
my complaint vs. Manila Mayor Lim;
The Secretary of the Department of Interior and Local
Government for not accepting my complaint vs. Manila Mayor Lim.
Lim - Mayor of Manila, Philippines; Moreno - Vice Mayor of Manila, Philippines;
Binay - Mayor of Makati City, Philippines; Vice-Mayor of Makati, Philippines;
Benhur Abalos - Mayor of Mandaluyong City, Philippines; Vice-Mayor of Mandaluyong City Philippines;
Belmonte - Mayor of Quezon City, Philippines; Herbert Bautista - Vice Mayor of Quezon City,Philippines;
The Commissioner of the Civil Service Commssion - Philippines for not accepting
my complaint vs. Manila Mayor Lim;
The Secretary of the Department of Interior and Local
Government for not accepting my complaint vs. Manila Mayor Lim.
Subscribe to:
Comments (Atom)
image of registry return receipt of letter addressed to Makati councilor J. J. Binay
